SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals’ Lasofoxifene Demonstrates Anti-Estrogen Therapy Increases Immunotherapy Efficacy by Promoting Antitumor Activity of Eosinophils
01 oct. 2024 09h00 HE | Sermonix Pharmaceuticals Inc.
The findings were published Sept. 27 in the peer-reviewed journal Science AdvancesLasofoxifene was more effective than fulvestrant in inhibiting estrogen activity in mice models COLUMBUS, Ohio,...
Caring House CP 5.7.24 _ed
Caring House Receives $3 Million Challenge Grant for Expansion of Durham Hospitality House
30 mai 2024 16h12 HE | State Employees' Credit Union (SECU)
Caring House Receives $3 Million Challenge Grant for Expansion of Durham Hospitality House